tiprankstipranks
Alnylam Pharmaceuticals (ALNY)
NASDAQ:ALNY
US Market
ALNY
Alnylam Pharma
RESEARCH TOOLSreports
Want to see ALNY full AI Analyst Report?

Alnylam Pharma (ALNY) Ratios

1,438 Followers

Alnylam Pharma Ratios

ALNY's free cash flow for Q1 2026 was $0.82. For the 2026 fiscal year, ALNY's free cash flow was decreased by $ and operating cash flow was $0.13. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.13 2.76 2.78 3.08 3.51
Quick Ratio
 3.06 2.71 2.71 2.99 3.34
Cash Ratio
 1.27 1.13 0.81 0.84 1.13
Solvency Ratio
 0.15 0.09 -0.05 -0.10 -0.29
Operating Cash Flow Ratio
 0.53 0.36 >-0.01 0.11 -0.70
Short-Term Operating Cash Flow Coverage
 15.61 0.00 -0.07 0.00 0.00
Net Current Asset Value
$ 165.14M$ -126.49M$ -877.61M$ -1.07B$ -1.01B
Leverage Ratios
Debt-to-Assets Ratio
 0.25 0.26 0.65 0.34 0.37
Debt-to-Equity Ratio
 1.18 1.62 40.89 -5.92 -8.34
Debt-to-Capital Ratio
 0.54 0.62 0.98 1.20 1.14
Long-Term Debt-to-Capital Ratio
 0.53 0.56 0.97 1.28 1.18
Financial Leverage Ratio
 4.77 6.29 63.20 -17.36 -22.41
Debt Service Coverage Ratio
 1.93 2.17 -0.31 -2.19 -5.97
Interest Coverage Ratio
 2.66 1.99 -1.25 -2.33 -5.03
Debt to Market Cap
 0.03 0.02 0.08 0.04 0.04
Interest Debt Per Share
 11.71 11.69 22.60 11.42 12.13
Net Debt to EBITDA
 -0.71 -0.68 -9.94 -1.91 -0.49
Profitability Margins
Gross Profit Margin
80.89%81.77%85.62%83.02%83.73%
EBIT Margin
13.35%13.51%-10.48%-17.08%-93.60%
EBITDA Margin
14.31%15.00%-7.95%-14.12%-89.31%
Operating Profit Margin
17.54%13.51%-7.87%-15.43%-75.68%
Pretax Profit Margin
13.68%8.70%-16.79%-23.71%-108.63%
Net Profit Margin
13.46%8.45%-12.37%-24.08%-109.04%
Continuous Operations Profit Margin
14.20%8.45%-12.37%-24.08%-109.04%
Net Income Per EBT
98.43%97.09%73.71%101.55%100.37%
EBT Per EBIT
77.96%64.43%213.34%153.63%143.55%
Return on Assets (ROA)
11.25%6.32%-6.56%-11.49%-31.90%
Return on Equity (ROE)
98.29%39.76%-414.62%199.53%714.91%
Return on Capital Employed (ROCE)
19.90%14.33%-5.79%-9.86%-28.26%
Return on Invested Capital (ROIC)
19.66%13.74%-4.06%-9.72%-27.84%
Return on Tangible Assets
11.25%6.32%-6.56%-11.49%-31.90%
Earnings Yield
1.46%0.60%-0.93%-1.84%-3.91%
Efficiency Ratios
Receivables Turnover
 4.85 4.78 5.55 5.58 4.36
Payables Turnover
 6.47 5.85 3.66 5.59 1.72
Inventory Turnover
 9.75 8.19 4.12 3.48 1.31
Fixed Asset Turnover
 6.06 5.25 3.24 2.52 1.40
Asset Turnover
 0.84 0.75 0.53 0.48 0.29
Working Capital Turnover Ratio
 1.57 1.58 1.09 0.93 0.51
Cash Conversion Cycle
 56.28 58.63 54.62 104.98 150.46
Days of Sales Outstanding
 75.26 76.42 65.80 65.44 83.72
Days of Inventory Outstanding
 37.45 44.59 88.62 104.82 278.83
Days of Payables Outstanding
 56.43 62.37 99.80 65.28 212.09
Operating Cycle
 112.71 121.00 154.42 170.26 362.55
Cash Flow Ratios
Operating Cash Flow Per Share
 5.36 4.00 -0.07 0.83 -4.45
Free Cash Flow Per Share
 4.83 3.55 -0.33 0.34 -5.04
CapEx Per Share
 0.54 0.45 0.27 0.50 0.59
Free Cash Flow to Operating Cash Flow
 0.90 0.89 5.12 0.40 1.13
Dividend Paid and CapEx Coverage Ratio
 9.96 8.93 -0.24 1.67 -7.51
Capital Expenditure Coverage Ratio
 9.96 8.93 -0.24 1.67 -7.51
Operating Cash Flow Coverage Ratio
 0.56 0.41 >-0.01 0.08 -0.41
Operating Cash Flow to Sales Ratio
 0.17 0.14 >-0.01 0.06 -0.52
Free Cash Flow Yield
1.61%0.89%-0.14%0.18%-2.12%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 68.48 166.04 -107.99 -54.31 -25.57
Price-to-Sales (P/S) Ratio
 9.26 14.03 13.36 13.08 27.88
Price-to-Book (P/B) Ratio
 36.76 66.01 447.73 -108.36 -182.78
Price-to-Free Cash Flow (P/FCF) Ratio
 61.92 111.94 -705.29 569.99 -47.15
Price-to-Operating Cash Flow Ratio
 55.45 99.40 -3.61K 229.54 -53.43
Price-to-Earnings Growth (PEG) Ratio
 0.03 -0.79 2.84 0.87 -0.88
Price-to-Fair Value
 36.76 66.01 447.73 -108.36 -182.78
Enterprise Value Multiple
 64.01 92.81 -177.89 -94.49 -31.70
Enterprise Value
 39.28B 51.71B 31.81B 24.40B 29.37B
EV to EBITDA
 64.01 92.81 -177.89 -94.49 -31.70
EV to Sales
 9.16 13.92 14.15 13.35 28.31
EV to Free Cash Flow
 61.24 111.12 -747.01 581.74 -47.89
EV to Operating Cash Flow
 55.09 98.68 -3.83K 234.27 -54.27
Tangible Book Value Per Share
 8.09 6.02 0.53 -1.77 -1.30
Shareholders’ Equity Per Share
 8.09 6.02 0.53 -1.77 -1.30
Tax and Other Ratios
Effective Tax Rate
 -0.04 0.03 0.26 -0.02 >-0.01
Revenue Per Share
 32.26 28.35 17.61 14.64 8.53
Net Income Per Share
 4.34 2.39 -2.18 -3.52 -9.30
Tax Burden
 0.98 0.97 0.74 1.02 1.00
Interest Burden
 1.02 0.64 1.60 1.39 1.16
Research & Development to Revenue
 0.33 0.36 0.50 0.55 0.85
SG&A to Revenue
 0.30 0.33 0.43 0.44 0.74
Stock-Based Compensation to Revenue
 0.07 0.09 0.12 0.12 0.22
Income Quality
 1.24 1.67 0.03 -0.24 0.48
Currency in USD